Showing results (171-180 of 232) with videos related to
Sort By:
Pageof 24
Tumori|March 1, 1995
Comparison of immunoassays for tumor markers CA 19-9, CA 15-3 and CA 125: data from an international quality assessment schemeA Pilo, G C Zucchelli, R Cohen, et al.The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010
(131)I-MIBG treatment of pheochromocytoma: low versus intermediate activity regimens of therapyM R Castellani, S Seghezzi, C Chiesa, et al.Cancer Detection and Prevention|January 1, 1987
Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibodyG Buraggi, L Callegaro, A Turrin, et al.European Journal of Nuclear Medicine|November 18, 1998
Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumoursA Chiti, S Fanti, G Savelli, et al.Anticancer Research|January 12, 2000
Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancerP Foa, M Fornier, R Miceli, et al.The International Journal of Biological Markers|October 1, 1994
Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigenM Correale, H Arnberg, P Blockx, et al.The International Journal of Biological Markers|July 29, 1998
Chromogranin A measurement in neuroendocrine tumorsL Ferrari, E Seregni, A Martinetti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
Orchiectomy alone in clinical stage I nonseminomatous testis cancer: a critical appraisalG Pizzocaro, F Zanoni, A Milani, et al.The International Journal of Biological Markers|April 1, 1994
Evaluation of cytokeratin 19 serum fragments (CYFRA 21-1) in patients with lung cancer: results of a multicenter trialE Bombardieri, E Seregni, A Bogni, et al.International Journal of Oncology|May 12, 2011
Reliability of immunoradiometric assays for sex-hormone binding globulin, androstenedione, 17-Beta estradiol and tumor-markers cea and cb15.3 to assess the biological response of megestrol-acetate treatment in patients with advanced breast-cancerC Botti, A Bogni, E Seregni, et al.Pageof 24